Investment Summary

HBM Partners AG and Mirae Asset Private Equity Invest In Valo Health

On January 11, 2021, private equity firms HBM Partners AG and Mirae Asset Private Equity invested in life science company Valo Health

Investment Highlights
  • This is HBM Partners AG’s 44th and Mirae Asset Private Equity’s 1st transaction in the Life Science sector.
  • This is HBM Partners AG’s 34th and Mirae Asset Private Equity’s 2nd transaction in the United States.
  • This is HBM Partners AG’s 7th and Mirae Asset Private Equity’s 2nd transaction in Massachusetts.

Investment Summary
Date 2021-01-11
Target Valo Health
Sector Life Science
Investor(s) HBM Partners AG
Mirae Asset Private Equity
Deal Type Venture

Target

Valo Health

Lex­ing­ton, Massachusetts, United States
Valo Health is a technology company built to transform the drug discovery and development process using human-centric data and artificial intelligence driven computation. Valo Health was founded in 2019 and is based in Lex­ing­ton, Massachusetts.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 2

Investor

HBM Partners AG

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 2001
PE ASSETS 3.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

HBM Partners is a private investment firm focused on investing in entrepreneurial biopharma and other healthcare-related companies in Europe, North America, India and other Emerging Markets. HBM looks to invest $5 to $50 million per transaction and will consider private and public companies. HBM Partners was established in 2001 and is headquartered in Zug, Switzerland.

DEAL STATS #
Overall 51 of 66
Sector (Life Science) 44 of 57
Type (Venture) 41 of 53
State (Massachusetts) 7 of 13
Country (United States) 34 of 44
Year (2021) 3 of 15
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-11 Genalyte

San Diego, California, United States

Genalyte is a healthcare diagnostics and analytics company that improves patient outcomes and lowers cost with real-time results for physicians and patients. Genalyte was founded in 2007 and is based in San Diego, California.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-01-13 IO Biotech

Copenhagen, Denmark

IO Biotech is a clinical stage biotech company developing disruptive immune therapies for the treatment of cancer. IO Biotech's pipeline of first-in-class immune modulating anti-cancer therapies is based on a unique platform technology enabling the activation of T cells that are specific for immune inhibitory molecules. IO Biotech was founded in 2014 and is based in Copenhagen, Denmark.

Buy -
Investor

Mirae Asset Private Equity

Category Private Equity Firm
Size Large
Type Sector Agnostic
DESCRIPTION

Mirae Asset Private Equity is the private equity arm of asset manager Mirae Asset Global Investments. Mirae Asset Private Equity will consider opportunities across South Korea including buyouts, growth capital financings, and special situations. Mirae Asset Private Equity is based in Seoul.

DEAL STATS #
Overall 4 of 4
Sector (Life Science) 1 of 1
Type (Venture) 2 of 2
State (Massachusetts) 2 of 2
Country (United States) 2 of 2
Year (2021) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-18 CGV

Seoul, South Korea

CGV pioneered the concept of multiplex cinemas in Korea and operates and manages 94 screens in 11 strategically located sites across Korea. CGV was founded in 1999 and is based in Seoul, South Korea.

Buy -
Mergr

Product

Company

Legal